ACNP 61st Annual Meeting: Keyword Index

• Key Word Submission Number(s)

• (2R,6R)-hydroxynorketamine P216, P293

• (2S,6S)-HNK P375

• (R,S)-ketamine 3.2, 50.3, P26, P79, P135, P350, P355, P375

• [11C]UCB-J P198, P484

• 22Q11 Deletion Syndrome P113, P117

• 22Q11.2 Deletion Syndrome P500, P517, P524, P581

• 2-Deoxyglucose 43.4

• 2-Photon Techniques P609, P630

• 3D Genome P219

• 5C-CPT 40

• 5-HT P359

• 5-HT2A Receptor 34.2, P254, P349, P358, P426, P722, P779

• 5-HT4 Receptor 3.2, P79

• 7q11.23 Duplication P402

• 7T MRS P166

• ABCD P143, P144

• ABCD study P125, P294

• ABI P396

• Abnormal Involuntary Movement Scale (AIMS) P558

• Abstinence 15.3, P692, P719, P692, P719

• Academic / Industry Collaboration 13

• Accelerated Aging 9, 9.4, P340

• Acetylcholine 59, 59.2, 59.3, 59.5, P16, P98, P381, P483, P583

• Acetylcholinesterase P20

• Acid-Sensing P694

• Acoustic Startle P83

• Acoustic Startle Response P88, P566, P645

• Actigraphy P328, P577

• Action Potentials P571

• Activated Microglia P608

• Active Avoidance P169, P417, P463

• Active Duty Military 60.3

• Acute Agitation P567

• Acute and Chronic Stress 33.1, P62, P382, P747, P761

• Acute Effect P687

• Acute Stress 11.4, 36.2, 50.2, 56, P462, P504

• Acute Traumatic Stress P61

• Acute Treatment P28

• Adaptive Immunity P222

• Addiction 1, 15, 34.4, 37, P197, P604, P634, P635, P674, P720

• Addiction Circuitry P647

• Addiction Comorbidity P145, P676

• Addiction Genetics P673

• Addiction Phenotypes P602, P657, P702

• Addictions Neuroclinical Assessment P781

• Adenosine A2A Receptor P608

• Adenosine Monophosphate Activated Protein Kinase (AMPK) P727

• Adjunctive Treatment 50.5, P229

• Adolescence 15.2, 42.2, P117, P132, P143, P156, P476, P580, P664, P691, P721, P732, P793

• Adolescent 1.3, 26.1, P135, P142, P257, P303, P328, P620, P792

• Adolescent Alcohol P721

• Adolescent Alcohol Use 25.5

• Adolescent Anxiety P44, P76

• Adolescent Binge Drinking P605

• Adolescent Brain Cognitive Development Study P141, P162

• Adolescent Depression 26, 26.3, P154, P161, P256, P390

• Adolescent Development 25.3

• Adolescent Stress P107, P89, P457

• Adrenarche P137

• Adult Brain P429

• Adult Clincial Anxiety P782

• Adult Hippocampal Neurogenesis P383

• Adult Smoking and Alcohol Traits P679

• Adult Stem Cells P489

• Advantage of the Combination of Therapies 3, 3.4

• Adverse Childhood Events 45, P129

• Affect 10

• Affect Regulation P273

• Affective Behavior P132

• Affective Components of Pain P660

• Affective Disorders P109

• Affective Instability P326

• Affective Psychopathology P715

• Affective Touch P803, P805

• African Americans 14.3, P172

• Age of Onset 47.3

• Aggression P104, P196, P249

• Aggressive Behavior 33, 33.2

• Aging 37, 37.4, 47.3, 59.4, P4, P9, P18, P20, P637, P680

• Agitation 60.5

• Agression P792

• Air Pollution P159

• AK-1402 P80

• Alcohol 29, 46, 46.5, P10, P93, P430, P599, P626, P643, P648, P653, P664, P672, P680, P702, P716, P720, P752, P759, P687

• Alcohol Abstinence P697, P754

• Alcohol Abuse P645, P649

• Alcohol and Drugs P762

• Alcohol and Substance Use Disorders 14.5, 34.3, P610, P633, P681, P690, P705, P708, P748, P749

• Alcohol Consumption P681, P690, P742

• Alcohol Dependence P668, P695, P697, P740, P747

• Alcohol Use P650

• Alcohol Use Disorder 46.4, P15, P622, P637, P642, P647, P651, P668, P684, P694, P773, P781

• Alcohol Use Disorder - Treatment 3.5, 34.5, 46, 46.2, 60, 60.2, 60.3, P172, P431, P625, P626, P627, P628, P663, P670, P678, P710, P711, P742

• Alcohol Use Disorder and Drug Addiction P145, P613

• Alcoholic Liver Disease P181

• Alcoholism P670

• Alcohol-Preferring (P) Rats P658

• Allodynia P446

• Allopregnanolone P306, P307, P348

• Allostatic Load P587

• Alpha7 Nicotinic Acetylcholine Receptor P595

• Alpha-Adrenergic 60

• Alternative Splicing 57.1, P399, P536

• Alzheimer’s P316, P441

• Alzheimer’s Dementia 32.3, P400

• Alzheimer’s Disease 60, 60.5, P1, P5, P6, P16, P19, P21, P394, P398, P403, P411

• AMPA P495

• AMPA Glutamate Receptors P459, P482

• Amygdala 20, 20.3, 31.2, P87, P40, P61, P88, P94, P104, P289, P290, P682, P723, P756, P784

• Amygdala Ablation P70

• Amygdala-Based Networks P770

• Analgesia 35.4, P718

• Analysis 32

• Anandamide 35.2

• Angiogenesis P371

• Anhedonia 50, 54.1, P250, P279, P291, P351, P363, P370, P390

• Animal Models 40.4, P32, P360, P437, P741, P746, P750

• Animal Research 6

• Animal to Human Translation 22

• Anomalous Self Experience 52.3

• Anorexia Nervosa P184, P185, P186, P188, P189

• Antagonist Ligands P629

• Anterior Cingulate Cortex (ACC) P205, P290, P376, P427, P660, P769

• Anterior Insula P457, P774

• Anti-Adrenergic 60.3, 60.5

• Anticholinergic Medication Burden P529, P533

• Antidepressant P208, P327, P330, P350, P351, P368

• Antidepressant Mechanisms P354

• Antidepressant Response P387

• Antidepressant Treatment Practice P76

• Antipsychotic P573

• Antipsychotic Drugs P575

• Antipsychotic Induced Weight Gain P177, P178, P497

• Antipsychotic Treatment P538, P565

• Antipsychotic Treatment Practice P343

• Antipsychotic-Induced Metabolic Dysfunction 43.4, P178, P180

• Antipsychotic-Induced Weight Gain P551

• Antipsychotic-Naïve First-Episode Schizophrenia 50.4, P499

• Antipsychotics P485, P527

• Anxiety 3.2, 15, 15.1, 17, 17.2, 48.2, 51, 51.3, 56.2, P21, P32, P34, P46, P51, P53, P56, P69, P77, P91, P189, P199, P242, P359, P374, P469, P717, P87, P208, P301, P342

• Anxiety & PTSD 29, P24, P36

• Anxiety and Depression 54.1, 54.2, P95

• Anxiety and Stress 17.3, 56.5, P82, P93, P645, P754

• Anxiety Circuitry P90, P100, P754

• Anxiety Disorders P39, P778

• Anxiety-Like Behavior P25

• Apathy P301

• Apnea-Hypopnea Index P588

• Approach/Avoidance P44, P212, P631, P649, P787

• Approach-Avoidance Conflict P259, P46, P54

• Apremilast 46.2

• Arc P604

• Arcuate P192

• Arginine Vasopressin P229

• Arketamine P354

• Arousal 56.3

• Artifical Transcription Factors P222

• ASD 21.2, P149, P151, P396, P409

• ASD Core Symptoms P121

• Associative Learning 20, P807

• Astrocyte P194, P414, P436, P501, P636, P775

• Astrocyte-Derived Exosomes (ADE) P335

• Astrocyte-Neuron Interaction P611

• Astrocyte-Neuronal Lactate Shuttle P436

• Astrocytes P224, P323, P692

• Astrogliosis P405

• ATAC-seq P59

• Aticaprant 50

• Attention 8.3, 39, 40, 40.2, 40.3, 40.4, P124

• Attention Deficit Hyperactivity Disorder (ADHD) 45.3, P106, P122, P139, P140, P149, P166, P167, P199, P266, P267, P409, P433, P434, P451, P711, P115, P126, P778

• Atypical Antipsychotics P455

• Auditory Cortex P576

• Auditory Mismatch Negativity P515, P564, P785

• Auditory Processing 21.3, P153, P576

• Autism P114, 40.4, 57.4, P108, P112, P120, P121, P123, P128, P159, P395, P396, P399

• Autism & Depression P320

• Autism Spectrum Disorder and Related Syndromes 21, P115, P406

• Autism Spectrum Disorders 21.3, P111, 33.4, 57.1, P133, P148, P153, P503

• Automated Computational Language Speech Faces 10.4

• Automated Natural Speech Analysis 10, 10.3, 52.2, P14

• Autonomic Nervous System 22.1

• Aversion P599

• Aversive Learning P53, P98, P101

• Avoidance 51.3, 56.3, P374

• Baeocystin P252

• Bariatric Surgery P187

• Basal Ganglia 20, P181, P182, P498

• Basal Nucleus P114

• Basolateral Amygdala 15.3, P27, P105, P119, P378, P689, P740, P759, P767, P774

• BDNF P35, P508, P569

• Bed Nucleus of the Stria Terminalis 56.5, P374

• Behavior P108, P170, P373

• Behavior Deficits P312

• Behavioral Economics P248, P710, P720, P809

• Behavioral Genetics P612

• Behavioral Model P80

• Behavioral Pharmacology P673, P705

• Behavioral Tasks P406, P510, P779

• Behavioral Variability P510

• Benzo[D]Thiazole P629

• Beta Arrestin Signaling 35.4

• Big Data 32, P367

• Big Data Analysis 32.2, P657

• Big Five Personality Factors P650, P801

• BIIB104 P495

• Binge P744

• Binge Alcohol Use 46.3

• Binge-Drinking P742

• Biobanks 24.5

• Biobehavioral Effects 54

• Bioeffect 27.2

• Bioinformatics P487

• Biological Aging P15

• Biologics 35.3

• Biomarker Development P585

• Biomarker Risk Assignment Algorithm 32.2

• Biomarkers 9.4, 35.3, 52.4, P169, P417, P463

• Bipolar Depression P228, P233, P388, P364

• Bipolar Disorder (BD) 39.2, 47, 47.1, 47.2, 47.3, 47.4, 52.2, 52.4, P535, P232, P238, P243, P122, P140, P155, P213, P223, P226, P265, P266, P267, P271, P274, P282, P289, P297, P303, P317, P339, P343, P364, P365, P455, P299, P326, P296, P338, P795

• Bipolar Electrode Montage P655

• Bipolar I Depression P272, P345

• Bipolar I Disorder P345, P287

• Bipolar II Disorder P228

• Bipolar Type II Depression P236

• Birth Cohort 32.2, P139

• Blinding P802

• Blood-Brain-Barrier 53.2, P579, P695

• BNC210 P28, P29

• BNST P212, P754

• Body Dysmorphic Disorder P423

• Body Weight P190

• BOLD fMRI Signal 36.3, P303

• Borderline Personality Disorder 51, 51.2, P201, P471, P472

• Brain Age P283

• Brain Aging P19

• Brain Based Markers For Depression P367, P369, P796

• Brain Circuit P547

• Brain Connectome P69, P520

• Brain Development 57, 57.4, P131, P133, P137, P156, P157, P637

• Brain Imaging P140

• Brain Imaging, fMRI P504, P649

• Brain Immune Gut Axis P313

• Brain Insulin Action 43, 43.2

• Brain Insulin Resistance 43.4

• Brain MRI P284

• Brain Networks P124, P282, P273

• Brain Organoids P293, P616

• Brain Plasticity 18.3, P219

• Brain Regulation of Metabolism P158

• Brain Stimulation P380

• Brain Structural Connectivity P731

• Brain Structure P294

• Brain Transcription P222, P420

• Brain-Behaviour Relationships 32.5, P513

• Brain-Body Communication 11

• Brain-Derived Neurotrophic Factor P209

• Brain-Phenotype Relationships 25.2

• Breast Cancer P527

• Brief Negative Symptom Scale (BNSS) P577

• Buprenorphine P616, P803

• Buprenorphine Maintenance P696

• Bupropion P707

• Buspirone P426

• Calcium Imaging P23

• cAMP Signalling P218, P568

• Cancer 16.5, P179, P435, P709

• Cannabidiol 1.3, 16.5, P179, P435, P709

• Cannabinoid 1, P566

• Cannabinoid Receptor P178, P718

• Cannabis 1, 1.4, 35.2, P18, P659, P685, P705, P706, P709, P712, P714, P717, P718, P743, P664

• Cannabis Concentrates P715

• Cannabis Use P176, P199, P525, P671, P702, P715

• Cannabis Use Disorder 1.5, 35.1, 35.2, P176, P657, P714, P719

• Canonical Correlation Analysis (CCA) 31.1, P389

• Cardiac Reactivity P303

• Cardiac Sensation P30

• Cardiometabolic Disorders 22

• Cardiovascular Disorders P57

• Cardiovascular Function P371

• Career Development P444

• Cariprazine P342, P345, P359

• Catecholamine P790

• Caudate 44.5

• CB1 Receptor 35.1, P775

• CBD P717

• CBT 3.5

• CD44 P226

• Celecoxib P317

• Cell-Specific P603

• Cell-Type Diversity 58

• Cell-Type Specific Transcription P677

• Central Amygdala 46.4, P93, P105, P748

• Central Nucleus of the Amygdala P103

• Cerebellum 42.4, P498, P513

• Cerebral Cortex 40.2, 59.3, P121

• cFos P766

• c-Fos-expressing ensembles P619

• CGRP 16.2

• Chemogenetics 53.3, 53.4, 53.5, P104, P175

• Chemokines P552

• Chemotherapy-Induced Peripheral Neuropathy P446

• Child Abuse And Neglect 31

• Child And Adolescent Psychiatry 28.3

• Child Psychopharmacology P163

• Childhood Adversity P162

• Childhood Anxiety P47

• Childhood Emotional Maltreatment 31.3

• Childhood Psychiatric Symptoms P162

• Childhood Trauma 36, P638, P781, P805

• Childhood-Onset Schizophrenia P168

• Children P38

• Children And Adolescents P137

• Choice Procedure P729

• Choking P565

• Cholesterol Biosynthesis 58.5

• Choline P549

• Cholinergic Interneuron P195

• Cholinergic System 59.4, P542

• CHRNA5 P679

• Chronic Pain P436, P447

• Chronic Social Defeat Stress P89, P99

• Chronic Stress 42.3, P174, P217, P356, P384, P462, P776

• Chronic Unpredictable Mild Stress 20.3, 50.3, P212

• Chronotype P143

• Cilia 4, 4.1, 4.2, 4.3, 4.4

• Circadian Rhythms 30, P401, P477, P532, P704, P577

• Circuit 42.4

• Circuit Development 42

• Circuit Optogenetics P809

• Circuitry-Based Approach 18.3, P65, P804

• Classification P50

• Clinical Assessment P559

• Clinical Development 50.5

• Clinical Heterogeneity 48.5, P516

• Clinical High Risk For Psychosis P516, P525

• Clinical Outcome Assessments 2, P163, P337

• Clinical Pain Standards P407

• Clinical Psychiatry P287, P440

• Clinical Psychopharmacology P408

• Clinical Trial Methodology P118, P444, P450, P560, P625

• Clinical Trials 2, 3.5, 46.2, 54.2, P8, P236, P245, P431, P444, P564, P625, P802

• Clomipramine 27.2

• Closeness P453

• Clozapine P563

• Cluster Analysis P123

• CMV P224

• CNS Clinical Trials 34.5, P783

• CNS drugs P448

• CNV P534

• Co-Abuse P621

• Co-Activation Pattern Analysis P256

• Cocaine 53.4, P619, P674, P688, P689, P720, P727, P730, P602

• Cocaine Addiction 10.4, 25.5, 34.3, P635, P667, P703

• Cocaine And Opioid Use Disorders 34.2, P621, P682

• Cocaine Craving P603

• Cocaine Seeking P613

• Cocaine Self-Administration P603, P692, P725, P756

• Cocaine Self-Administration And Reinstatement P761

• Cocaine Sensitivity P669, P721

• Cocaine Sex Differences P174, P727

• Cocaine Use Disorder P656, P638, P734, P638, P734

• Cocaine-Seeking Behavior P692

• Co-Expression Network Analysis P540

• Cognition 6, 30, 39.4, 40.2, 59.4, P12, P508, P13, P20, P131, P160, P235, P270, P408, P437, P484, P490, P494, P500, P506, P533, P534, P543, P553, P555, P786

• Cognitive Behavioral Therapy 7.5, P44

• Cognitive Control 40, P194, P649, P711, P751

• Cognitive Decline P8, P17, P400, P397

• Cognitive Effort P261

• Cognitive Enhancement P45

• Cognitive Flexibility 21.4

• Cognitive Impairment 39.2, P486, P495, 32.3, P14, P247, P435

• Cognitive Impairment Associated With Schizophrenia 9.4, 32.2, P505, P542, P560, P581

• Cognitive Inflexibility P454

• Cognitive Neuroscience 39.4, P262, P638

• Cognitive Outcome Prediction P509

• Cognitive Performance P801

• Communication P123

• Community Detection P123

• Comorbid Insomnia Obstructive And Sleep Apnea (COMISA) P588

• Comorbidity 22

• Comorbidity depression and CVD 22.3

• Complement Component 3 P312

• Complement Pathway P318

• Compulsive Behavior P752

• Compulsive Drug Intake P599

• Computational Cognitive Neuroscience P51, P126

• Computational Genomics P531

• Computational Modeling 39.2, 39.3, P54, P53

• Computational Models Of Decision-Making 51.3, P280, P652, P653

• Computational Neuroscience P641

• Computational Psychiatry 39, 39.5, 49, P52, P126, P183, P518

• Computational Reinforcement Learning Model 51, 51.1, 51.2, P789

• Computerized Cognitive Training 3.4

• COMT Inhibitor P711

• Concussion P124

• Conditioned Place Preference 4.3, P727

• Conflict Monitoring P37

• Connectivity P233, P255

• Content Validity Of A Scale P337

• Contextual Fear P96, P413

• Continuous Performance Task P273

• Convolutional Neural Network (CNN) P442

• Copy Number Variants P205, P421, P524, 21.1, P537

• Copy Number Variation 21, P151

• Cortical Columns P808

• Cortical Development P141

• Cortical Morphology 32.5

• Cortical Thickness P141

• Cortical Volume 57.2

• Corticosterone P25

• Corticosterone Response To Stress 11.5

• Corticostriatal Circuit 20, P168

• Cortico-Striatal-Thalamo-Cortical Circuits P763

• Corticotropin Releasing Hormone 11.3

• Corticotropin-Releasing Factor (CRF) P104, P777, P747

• Corticotropin-Releasing Hormone P92, P747

• cortisol P684, P38, P648

• Cortisol Response To Stress 17.3, P628

• COVID-19 14, 14.5, P36, P38, P76, P264, P454, P798

• COX-1 and COX-2 P24

• Craving P635

• C-Reactive Protein P68, P264, P627

• CREB P4

• CRH P119, P464

• CRH+ neurons 11, 11.2

• CRISPR/Cas9 P483

• Critical Periods 42.4

• Cross-Species Translation 7, 21.1, 29, P585

• CSF P798

• CSF sTREM2 P7

• CSF1R P404

• Cue Reactivity P622, P642

• Cue Reinstatement P608

• Cue-Induced Craving 15.3

• Cue-Reactivity P626, P669

• Cytochrome P450s 27.1

• cytokines 17.1, P25, P114, P246, P313, P552, P553, P744, P797, P798, 46

• Cytoskeleton P489

• D1 agonist, D1-PAM P575

• D1 Dopamine Receptors P575, P730

• D2 Dopamine Antagonists P351

• D2 Dopamine Receptor 43.3, P195, P202, P483, P565

• D2 Medium Spiny Neuron P568

• Data Science 12, 32.3, 47.2, 52

• Database P466

• DBS P230

• d-cycloserine 3.3

• Decision Making 56, P46, P249, P259, P473, P519, P641, P790, P791

• Declarative Memory P19

• Deep Brain Stimulation P322, P369

• Deep Phenotyping P274

• Default Mode Network (DMN) P49, P277, P557, P257

• Defense Mechanism P794

• Delay Discounting P195, P413, P793

• Delirium P14

• delta9-tetrahydrocannabinol 1.3, P115, P717

• deltaFosB P206

• Delusions P519

• Dendrites 4.1, P111, P476

• Dendritic Arborization P108, P358

• Dendritic Spines P214, P688, P333, P437

• Dentate Gyrus 45.4, P2, P113, P379, P383

• Depression 3.4, 11.3, 14.3, 22, 27.3, 39.2, 39.4, 48.2, 48.3, 48.4, 50, P535, P208, P301, P7, P34, P69, P173, P218, P229, P231, P234, P239, P251, P257, P260, P268, P273, P281, P284, P292, P294, P302, P305, P315, P325, P327, P331, P334, P340, P345, P348, P351, P352, P353, P357, P367, P382, P386, P455

• Depression And Anxiety P79, P176, P215, P264, P371

• Depression And/Or Anxiety P276

• Depression Inflammation Cytokine 14.2, P317

• Depression Subtypes P389

• Depression Treatment Response P286

• Depression, Synaptic Aberations 18.4

• Depressive Disorders P336

• Depressive Symptoms P319

• Depressive-Like Behavior P207

• Depth Perception P808

• Development 36.5

• Developmental Neuroscience 25

• Developmental Psychopathology 7.5, 12, 31.1, P56, P125, P800

• Developmental Sensitive Period 42

• Developmental Tools, Techniques, And Strategies 38

• Developmental Trajectory 15.1, 31, 42.1, 42.3, P169

• Dexmedetomidine, Agitation, Locus Coeruleus, Alpha2-Adrenergic P567

• Diagnostic Specificity 7.5

• Diet P81

• Diffusion MRI P124, P138

• Diffusion Tensor Imaging (DTI) 7.4, 21.4, 47.3, P9, P47, P230, P267, P743, P687

• Diffusion Weighted Imaging 21.1, P146, P499

• Digital Phenotyping 52, 52.2, P332, P518

• Disease Modeling P221

• Disorders Of Glutamate P546

• Disparities 5.3

• Diverse Populations 24, 24.4

• Diversity And Inclusion 24.2

• DLPFC P233, P477

• DNA Methylation P60, P136, P296

• DNA, Whole-Genome, Sequencing, Schizophrenia P530

• DNMT P578

• Dopamine 33.3, 37.3, 43, 43.2, 43.3, 44.5, 58.3, P342, P91, P101, P132, P157, P159, P185, P220, P253, P288, P359, P373, P393, P409, P463, P562, P597, P600, P601, P634, P644, P656, P659, P675, P721, P733, P738, P763, P771, P775, P807

• Dopamine (D2, D3) Receptors P601

• Dopamine Circuitry 50.2

• Dopamine Circuits P34

• Dopamine D4 Receptor P629

• Dopamine Neuron P603

• Dopamine Receptor P223

• Dopamine Release P701

• Dopamine Transporter P409, P730

• Dopamine-Glutamate Co-Transmission 37.4, 37, 37.2

• Dopaminergic System 33.1, P541

• Dorsal Attention Network 51.1

• Dorsal Hippocampus P97, P412

• Dorsal Raphe P311, P357

• Dorsal Striatum 4.4, 20.3, 20.4, P253, P357, P428, P767, P204

• dorsolateral prefrontal cortex (DLPFC) P205, P535, P548, P655, 58.4, P540, P271

• Dorsolateral Striatum P760

• Dorsomedial Striatum P757

• DREADDs P615, 15.2

• Drinking P697

• Drinking Disorders P653

• Drug Addiction 10.3, 53, 53.3

• Drug Development P804

• Drug Discovery P722

• Drug Discovery - New Approaches P128

• Drug Discovery/Development P568

• Drug Liking 35.3

• Drug Metabolism P672

• Drug Relapse P598

• Drug Seeking P610, P772

• Drug Self-Administration P671, P743

• Drug Use Disorders 6, P405

• Drug-Drug Interaction P728

• Drugs 10

• DSM-5 P287

• Dual Orexin Receptor Antagonist (DORA) P588, P593, P720

• Dynamic Functional Connectivity P273

• Dynorphin P597, P765, P767

• Dysphoria P71

• Early Career Scientist Workshop 38

• Early Intervention Services P528

• Early Life Adversity 15, 15.1, 31.2, 42, 45.2, 45.5, P379

• Early Life Stress (ELS) 5, 7.3, 11.3, 15.3, 28.4, 29, 31.1, P81, P278, P479, P601, P74, P119, P132, P134, P379

• Early Life Trauma 15.4

• Early Psychosis 18.2, 52.3, P504, P520, P528

• Early Trauma P89

• Early-Life Adversity 42.1, P92, P109

• Eating Behavior P456

• Eating Disorders P182, P183, P186, P189, P191, P192

• Ecological Momentary Assessment 51.2, P164, P183, P268, P329, P496

• EEG P118, P142, P262, P395, P439, P470, P494, P500, P573

• EEG biomarkers 40.5, P77, P334, P469, P567, P573, P653, P751

• EEG connectivity P154

• EEG electrophysiology P503, P661, P778

• EEG/ERP electrophysiology 39.4, P561, P584

• Effective Connectivity P423

• Effort P376

• Effort Based Decision Making Task P554

• Effort-Cost Benefit Task P809

• E-I balance 15.2

• Electrical Field Modeling P331

• Electroconvulsive Therapy P283, P383

• Electroencephalography P320, P507, P595

• Electron Microscopy 21.4

• Electron Transport P339

• Electronic Cigarette (E-Cigarette) 1.5, P735

• Electronic Health Record (EHR) P529, P558, P676

• Electronic Medical Record 28.3, P284

• Electrophysiological Approaches P34

• Electrophysiology 44.2, 46.5, P175, P630

• Elevated Plus Maze P77

• Emotion Circuitry 25.4

• Emotion Processing P271

• Emotion Recognition 52.2

• Emotion Regulation 28.2, P33, P268, P788

• Emotional Arousal P72, P299, P648

• Emotional Dysregulation P329

• Emotional Memory 36.4

• Emotional Regulation P48, P277, P298, P386

• Emotional Stress P264

• Empathy P473

• Endocannabinoid System P63, P201

• Endocannabinoids 35, P22, P61, P566, P600, P635, P719, P761, P773, P805

• Endophenotypes P120

• Endothelial Function P579

• Energy Metabolism P190

• Engram 54.4

• Entorhinal Cortex 59.4, P394

• Entourage Effect P425

• Environment 9, 9.3, P769

• Environmental Risk Factors P32

• EPA P237

• Epidemiology 39.5

• Epigenetic Age Acceleration P683

• Epigenetic Biomarkers P60, P306

• Epigenetic Clock P15

• Epigenetics 47.4, P107, P207, P219, P225, P297, P399, P448, P459, P598, P672, P680

• Epigenome Wide Association Studies P296

• Epigenomics P667

• Epilepsy P410, P70

• Episodic Memory 36.5, 39.3, P648

• Episodic Memory Rodents P772

• eQTL 57.2

• ERP 26.1, P494

• Escitalopram P317

• Esketamine P354, P724

• Estradiol P231, P305, P306, P591

• Estrogen Receptor P84, P305

• Estrous Cycle P736

• Ethanol P745

• Event Related Potentials P467

• EWAS P60

• Excitation-Inhibition Balance P411

• Excitatory / Inhibitory Balance P398

• Excitatory Synapses 4.1, 18.4, P111, P411, P570, P111, P411, P570, P611

• Executive Function P138, P499, P671, P713

• Exercise P5

• Expansion Microscopy P548

• Expectancy P802

• Experience Dependent Plasticity 7.2

• Experimental Methods 39.5, P31

• Explainable-AI P125

• Exploration 51, 51.1, 51.2

• Explore-Exploit Dilemma P280, P790

• Exposome 28, 28.3

• Exposure-Response Model P29

• Expression Quantitative Trait Loci (eQTLs) 24, 24.4, 44

• Exteroception 49

• Extinction 36.2, P35, P602, P632

• Extinction and Reinstatement P753

• Extinction learning P130

• Extracellular vesicles P1, P297, P618

• Extrapyramidal symptoms P558, P243

• Eye Movements 8.2

• Eye-Tracking P503, 31.3, P197

• F-18 PET Imaging P796

• FAAH P63

• Face Emotion Processing P503

• Face Expression 8

• Face Expression Synchrony 8

• Facial Affect 8.4

• Facial Dysmorphology P517

• Facial Expression 25.4

• Familial Risk 28.5

• Familial Risk for MDD P256

• Familial Risk of Bipolar Disorder P304

• Family Study P424

• Fast Scan Cyclic Voltammetry P734

• Fast-Acting Antidepressant 18.4, P254

• Fatty Acid Amide Hydrolase 35.2

• Fatty Acid Amide Hydrolase, PET, Cannabis P201

• Fear P374, P87

• Fear Conditioning 36.3, P22, P97, P102, P375

• Fear Conditioning And Extinction 36, P33, P36, P50, P68, P82, P756

• Fear Extinction P84

• Fear Generalization 36.3, P26, P96

• Fear Regulation P94

• Fear-Potentiated Startle P82, P92

• Feeding 56.2

• Feeding Behavior 4.2, 56, P192, P193

• Fentanyl P615, P729, P745, P758

• Fetal Alcohol Spectrum Disorder P441

• Fetal Brain P429

• Fetal Brain Development 27.3

• Fetal Neurobehavior P136

• FGF-21 P364

• Fiber Photometry P758, P62, P385, P458, P463, P634, P752, P763

• First Episode Psychosis P493, P506, P551, P552

• First Episode Schizophrenia P576

• FKBP5 P479, P682

• Flame Retardant P127

• Fluorescence In Situ Hybridization P196

• Fluornitrazene P391

• Fluoxetine 27.2

• fMRI 10.3, 26, P43, P46, P105, P166, P467, P474, P622, P643, P644, P646, P712, P768, P780, P782, P299, P326

• fMRI Functional Connectivity 25.3

• fMRI Negative Affective Stimuli P45

• fMRI, Anxiety, Threat P39

• FMRP P150

• fNIRS P152, P197

• Focused Ultrasound 53.2

• Food Cues P456

• Food Insecurity P144

• Food Intake P190, P191

• Food-Reinforced Instrumental Task 20.4

• Fragile X Syndrome P118, P150, P152

• Free Fatty Acids P485

• Freesurfer P516

• Frequency Optimization 22.4, P380

• Frmi 31.4

• Frontal Pole (Brodmann’S Area 10) P481

• Frontolimbic Network P169

• Frontoparietal Network 40.2, P49, P126

• Frontopolar Cortex P655

• Frustration P164

• Functional And Structural MRI P39, P413

• Functional Brain Network P321

• Functional Capacity P560

• Functional Characterization P391

• Functional Connectivity 25, P155, P418, P462, P682, P155, P418, P462, P682, P368

• Functional Genomics 45, 57, 57.4

• Functional Impairment P685

• Functional Magnetic Resonance Spectroscopy P64, P298

• Functional Mri (fMRI) 28.2, P37, P41, P45, P56, P130, P147, P259, P262, P268, P470, P520, P543, P627, P638, P656, P706, P784, P788, P338, P512, P547, P699

• Functional Near-Infrared Spectroscopy P685

• Functional Network Connectivity 32.4, 45.2

• Functional Neuroimaging P505

• Functional Outcomes P505

• Functional Segregation P547

• Functioning 12

• GABA P119, P221, P223, P302, P430, P511

• GABA Neuron P432

• GABA Transmission P765

• GABA-A Receptors P110, P482, P667, P734

• GABA-A, Positive Allosteric Modulators P31, P75, P77

• GABA-B Receptors P734

• GABAergic Interneurons P350

• Gabaergic System 15.2, P80

• Gabapentin P728

• Galanin P607

• Gamma Synchronisation 59.2

• Gaze Dynamics 8

• Gaze-Following 8.2

• Gender Differences P433, P493, P543, P657

• Gene Discovery P151

• Gene Expression P110, P420, P429, P668, P670

• Gene Priming P598

• Gene Therapy 53, 53.2, 53.4

• Generalizability P50

• Generalized Anxiety Disorder P30, P42, P46, P75, P717

• Genes P295

• Genetic Ancestry 24.3, P429

• Genetic Association Study P678

• Genetic Disorder 21

• Genetic Mapping P673

• Genetic Mouse Models 21

• Genetic Risk Factor 28.5

• Genetic Variation P339

• Genetically Encoded Sensor 59, 59.5

• Genetics P562, P148, P421, P422, P475, P674

• Genetics Of Depression 22.3

• Genome-Wide Association Studies 24, P669, P795

• Genomics 24.2, 28, 48, 48.3, 48.4, P58, P530, P536, P674

• Geriatric 47, 47.1, 47.2, P13

• Ghrelin P431, P690, P742

• Ghrelin Receptor P742

• Gliosis P186

• Globus Pallidus P472

• Glucocorticoid Antagonists P628

• Glucocorticoid Receptor P213, P457

• Glucocorticoids P66

• Glutamate P64, P194, P366, P382

• Glutamate GABA P599

• Glutamate GABA Co-Release P777

• Glutamate Receptors P564

• Glutamate Transporter P414

• glutamate transporter (EAAT3) P621

• Glutamatergic P377

• Glutamatergic Synapses 15.2

• Glutamatergic Transmission 37.3, P459, P621

• Glutamine P302

• Glycosylation P475

• Goal-Directed P636

• Goal-Directed Behaviors 20.3, P767

• Goal-Directed Control 20.4

• GoNoGo P298

• GPCRs 4, 4.2, P393, P27, P218

• GPe P636

• GRAB-5HT P204

• Graph Theory P509

• Graph-based Analysis P56

• Gray Matter Volumes 9.4, P39

• Grey Matter Morphometry P129

• GrimAge acceleration 47.4, P365

• Growth Factors P571

• Gut Microbiome 5.5, 17, 17.1, 48.2, P69, P313, P314

• Gut Microbiota 11.5

• Gutamate P302

• GWAS 24.5, 44.4, P59, P200, P403, P535, P676

• Habenula 58.4

• Habit Formation 20.5

• Habits 20.3, 20.4, 20, P182, P636

• Hallucinations P583

• Head Twitch Response P349, P425

• Headache 60

• Health Disparities P665, P666

• Health Disparity 41

• Health Services P665

• Healthy Individuals P157, P646

• Heart Rate P86

• Heart Rate Variability 17, 17.1, 17.3, 22.1, P86

• Heartbeat Evoked Potential P30

• Hepatitis C P181

• Heritability P421

• Heritability Of Depression P793

• Heritability Of Substance Use Disorder P671

• Heroin 35, P641

• Heroin Seeking P766

• Heroin Self-Administration P601, P611, P617, P724, P753, P774

• Heterogeneous Stock Rats P612

• High Fat Diet P733

• High Potency Thc P620

• High Resolution Fmri P808

• High Risk P155

• High Throughput Screening P128

• High-Throughput P333

• Hippocampal Function 7.3, P762

• Hippocampal Subfields P523

• Hippocampus 3.2, 36.4, 36.5, 45, 45.2, 54.4, P2, P5, P21, P26, P40, P66, P96, P113, P260, P308, P346, P355, P435, P586, P3, P87

• Hipscs 44.2, P221

• Histone Variants P217

• HIV P84, P181

• HIV and Inflammation 14

• HIV-Associated Neurocognitive Disorder P405

• Hopelessness P269

• Hormones P643

• Hot Flashes P591

• Housing P260

• HPA axis P213

• Human And Non-Human Primates 8

• Human Brain Imaging P472, P686

• Human Connectome P282

• Human Connectome Project (HCP) P442

• Human Epigenetics/Microrna P472

• Human Genetics 24.3, 57.4, P177, P539, P677

• Human Immunodeficiency Virus P686

• Human Laboratory P626

• Human Microglia P214

• Human Neuroimaging 12, 23, 25.3, 31.2, 45.3, 47, 48.2, P48, P153, P185, P308, P367, P523

• Human Pluripotent Stem Cells 58

• Human Post-Mortem Brain P537, P214

• Human Postmortem Brain Tissue 44.3, P205, P532

• Hyperactivity P192, P586

• Hyperalgesia P446, P449

• Hyperarousal P103

• Hypertension 22.4

• Hypofrontality P483

• Hypomania P238

• Hypothalamic Development P171

• Hypothalamus 11.3, P192

• Ibudilast P627

• iDISCO mapping P474

• IGF-1 P617

• IL-6 P220

• Imaging 28, P541

• Imaging-Genetics 32.2, P366, P420

• Immune Biomarkers P556

• Immune Markers P114

• Immune Modulation 46.3, P291

• Immune Responses 15.4

• Immune System 17, P372

• Immunity & Neurodevelopment By Sex P158

• Immunometabolism P158, P291

• Immunotherapy 16.5, 35

• Implicit Association Test P275

• Impulsive Behavior P195, P675

• Impulsivity P145, P200, P280, P669, P699, P711, P793

• In Vivo Calcium Imaging 20.4, P21, P22, P104, P378, P417, P755

• In Vivo Electrophysiology P168, P586, P600

• In Vivo Fiber Photometry P34

• In Vivo Imaging 59.3, P91, P373

• In Vivo Microscopy 20.2

• Incentive Motivation P775

• Incentive Salience P203, P641, P713

• Income P452

• Incubation Of Cocaine Craving P174, P606

• Incubation Of Sucrose Craving P606

• Ind-Enabling Glp Studies P361

• Independent Component Analysis P54

• Individual Differences P203

• Individualized Head Models P655

• Induced Pluripotent Stem Cells (iPSCs) 44, 58.5, P216, P220, P406

• Infancy 5.4

• Infant Behavior P136, P147

• Infant Brain P146

• Infant Emotionality P146

• Infection P66

• Inflammation 14.3, 16.4, P161, P220, P237, P264, P346, P388, P435, P488, P554, P555, P627, P797, P798

• Inflammatory Disturbances 9.2

• Inflammatory Markers P1, P348

• Infralimbic Cortex P35, P191, P749, P760, P774

• Ingroup Bias 33.2, P196

• Inhibitor 35.2

• Inhibitory Control P643, P779, P800, P780

• Inhibitory Synaptic Transmission P411, P478

• Innate Immunity 17.2

• Innovative Methods 47.2

• Insomnia P592

• Insomnia Disorder P589, P593, P596

• Insula Connectivity P49

• Insular Cortex P193, P354, P468

• Insulin 43.3, P372

• Insulin Resistance P17

• Intellectual Disability P406

• Interferon P312

• Intergenerational Depression 45.4

• Intergenerational Transmission 45

• Intergenerational Transmission Of Stress P55

• Intergenerational Transmission Of Trauma 31, P85

• Interleukin 1 Receptor P311

• Interleukin 1Beta P311

• Interleukin-33 46.5

• Internalizing Disorders 26.2, P258

• International 47

• Interneurons P581

• Interoception 49, P30

• Intracranial EEG P631

• Intravenous Drug Self-Administration 1.3

• Intrinsic Metabolic Risk P551

• Intrinsic Motivation P809

• Intrinsic Neural Timescale P131

• In-Vivo Sirna Treatment P353

• Ion Channels 44.2, P406, P571

• iPSC P223

• IQ P534

• Irritability P336, P792

• Irritability/Aggression P507

• Isoform Co-Expression 57.1

• Isoform Transcriptome 57.1

• IV Alcohol P690

• IV- Ketamine 3.4, P227, P341

• Juvenile 42.3

• Juvenile Social Isolation 42.2, P658

• JZL184 P566

• Kappa Opioid Receptor 50, 50.2, 50.4, P363, P409, P471, P741, P767

• Kappa Opioid Receptor Antagonist 50.3, 50.5, P363, P739, P741

• Keratinocyte 16.3

• Ketamine 3, 3.5, P209, P218, P250, P275, P293, P318, P341, P372, P415, P416, P353

• Ketogenic Diet P19, P733

• Ketones P708

• Kinome P487

• Kynurenic Acid P522

• Kynurenine Pathway P397

• Lactate-To-Pyruvate Ratio P210

• Language 10.1

• Language Delay P123, P152

• Late-Life Depression 47.1, P1, P316, P344, P13, P387

• Latent Factor Analysis P279

• Latent States 25.4

• Lateral Habenula 42.1, P633, P758

• Lateral Hypothalamus P203

• Lateral Septum P432, P474, P609

• Latin America 9

• Learning 54.4

• Lemborexant P588, P593

• Lesion P65, P282

• LFP P580

• LGBTQIA+ needs 26.1, 26.3

• Lifetime Stress P683

• Lipopolysaccharide P335

• Liver Brain Axis P181

• Local Field Potentials P168, P770

• Locomotor Activity 4.3, P757

• Locus Coeruelus P630

• Locus coeruleus (LC) 56.2, 56.3, P378

• Long Term Potentiation P5

• Long-Acting Injectable Antipsychotics P490

• Longitudinal Analysis P162

• Longitudinal Imaging P258

• Longitudinal MRI P105, P524

• Longitudinal Study P274

• Long-Term Treatment P491

• lorcaserin P497

• LPS P311

• LSD P349, P358

• Lumateperone P228, P232, P238, P243

• Lurasidone P356

• M1 and M4 Muscarinic Receptors P480, P573, P575

• M1 Muscarinic Receptors P481

• M4 Muscarinic Receptors P573

• Macaques 8.2

• Machine Learning 32.4, 48, 52, P67, P125, P225, P330, P334, P341, P520, P547, P666, P752, P281

• Machine Learning Classification 48.4, P657

• MADRS P345

• Magnetic Resonance Imaging P731, P131, P300

• Magnetic Resonance Spectroscopy P511, P549

• Magnetoencephalography P275, P576

• Major Depression 48.5, P199, P259, P316, P479

• Major Depressive Disorder (MDD) 2, 3.3, 22.4, 50.5, 54, P338, P235, P237, P244, P278, P290, P295, P330, P335, P201, P210, P226, P240, P241, P263, P361, P362, P383, P778, P788, P795, P342, P338, P235, P237, P244, P278, P290, P295, P330, P335, P201, P210, P226, P240, P241, P263, P361, P362, P383, P778, P788, P795, P342, P242, P245, P262, P501

• Mania 47.1, P238, P339, P238, P339, P271

• Marijuana 35, 35.1, P620, P654

• Mast Cells P309

• Maternal Behavior P746

• Maternal Brain P660

• Maternal Immune Activation P127

• Maternal Inflamation P139

• Maternal Stress P55

• Matrix Metalloproteinase-9 (MMP-9) P556

• Matrix Metalloproteinases P78

• MCP-1/CCL2 P319

• MDD P58, P319, P785

• MDD, PTSD P464

• MDMA 10.2, P453, P803

• MDPV P768

• MDPV self-administration P726

• Mechanism Of Action P804

• Mechanotransduction 16.3

• Medial Amygdala P170

• Medial Orbitofrontal Cortex P417

• Medial Prefrontal Cortex 42.2, P24, P27, P94, P95, P97, P253, P310, P315, P502, P606, P723, P752, P779

• Medication Development P710

• Medication-Naive First Episode Psychosis 9.2, P521

• Meditation P470

• Medium Spiny Neuron P570

• MEG 51.1, P269, P546

• Melanocortin P191

• Memantine P398

• Memory 4.4, 21.4, 36, 54.4, 59, 59.5, P5, P11, P791

• Memory And Learning P581, P725

• Memory Engram Cell P26

• Mendelian Randomization 48.3, P514, P681

• Menopause 22.2, P11, P12, P308, P591

• Mental Health And Health Disparities 5.2, 14, 14.5

• Mental Health Disorders P32

• Mental Illness P224

• Mentalizing 8.2

• Mesolimbic Circuitry P463

• Mesolimbic Reward Circuitry P110, P646

• Meta-Analysis P116, P239, P549, P799

• Metabolic Biomarker P492

• Metabolic Function P11

• Metabolic Profile P232

• Metabolic Side-Effects P180, P178

• Metabolic Syndrome P178

• Metabolites P184

• Metabolomics 48, 48.2, 48.3, 48.4, 48.5, P551

• Metabolomics Signature P227

• Metabotropic glutamate receptor 2 (mGluR2) P27

• Metabotropic glutamate receptor 3 (mGluR3) P570

• metabotropic glutamate receptor 5 (mGluR5) P338, P639

• Metagenomics 48

• Metformin P497, P727

• Methamphetamine 10.2, P405, P439, P646, P733, P762, P803

• Methamphetamine Self-Administration P744

• Methamphetamine Use Disorder P639, P707, P772

• Methylphenidate P701, P166

• mGluR5 receptors P606

• Mice P468, P473

• Microarray P291

• Microbiome 5, 55, P159, P691

• Microbiota-Gut-Brain Axis 11.5, P158

• Microdialysis P167, P434, P721

• Microdosing With Psychedelics 10.1

• Microglia 11.2, P159, P160, P179, P310, P315, P404, P605, P651, P692, P7, P209

• Microglial Activation P405, P693

• Microrna P297

• Midazolam P416

• Mindfulness P49

• Miniscope P22

• Mirna 57.2, P278

• Mirnas P335

• Mismatch Negativity P580

• Mitochondria P364, 48.3, P225, P289, P339, P477

• Mitochondrial Dna 5.3, P81, P289, P530

• Mitochondrial Dna Copy Numbers P15

• Mitochondrial Dysfunction P210

• Mitochondrial Respiration P3

• Mobile Application P800

• Mobile Phones 52.4

• Model Bias 25.2

• Model Systems P352

• Moderators P415

• Modest Dose P687

• Molecular Genetics 24, P177, P373

• Molecular Imaging P404

• Monetary Incentive Delay Task P554

• Monetary Reward 26.3, P265

• Monocytes P489

• Monoiodoacetate Model Of Osteoarthritis P447

• Mood P456

• Mood And Addiction 25

• Mood And Anxiety Disorders P314

• Mood And Cognition P274

• Mood Disorders P99, P255, P277, P329, P332, P450, P261, P781, P797

• Mood Dysregulation P304

• Mood Stabilizers P343

• Mood, Childhood Stress P308

• Morphine 46, 46.3, P689

• Morphometry P472

• Motivated Behaviors P109

• Motivation 56.2, P363, P443, P572, P703, P737, P763, P787, P791

• Motor Learning P393

• Mouse Genetics P200

• Mouse Model P583

• Mouse Models 46.5, P24, P97, P694, P731

• mPFC 36, P169, P377, P461

• MPRA 44.4

• MR spectroscopy P325, P550

• MRI 32.3, P283, P12, P294, P301, P390

• mTOR P372, P606

• Multi-Ancestry 24.5, P151

• Multimodal Neuroimaging 5.4, 9, 25.4, 47.3, P146, P153, P402

• Multiple Sclerosis P284

• Multivariate Analysis 31.1

• Multivariate Approaches, Deep Learning P442

• Multivariate Pattern Analysis P50, P54

• Multivariate Statistics 32.5

• Mu-Opioid Receptor Agonist P718

• Mu-Opioid Receptors P391, P724

• Myd88 P605

• Myelin Imaging P402

• Myelination 7, 7.2, 7.3, 7.4, 21.2, 21.3, P47, P143

• N170 P395

• N-Acetylaspartate P549

• Naltrexone P707

• Narcolepsy P594

• Native Americans P467

• Natural Language Processing (NLP) 10.4, 52, 52.3, P14, P518, P641, P702

• Natural Setting 10.1, P323

• Naturalistic Drug Cues P642

• Near-Infrared Light P325

• Negative Affect P511

• Negative Emotionality P713, P782

• Negative Reinforcement P417, P634

• Negative Symptoms P579

• Negative Urgency P271

• Negative Valence System P633, P797

• Neighborhood Crime P147, P788

• Neighborhood Poverty P83

• Neocortex 57.3

• Neonatal P161

• Neonatal Opioid Withdrawal P673

• Neonates 27

• Network-Analysis P433, P164, P768

• Networks P368

• Neural Activity P354

• Neural Circuit And Animal Behavior 33.1, P99, P305

• Neural Circuits 22.2, P373, P379, P384

• Neural Decoding P99

• Neural Networks 18.3

• Neuroactive Steroid P242, P246

• Neurocircuitry P336

• Neurocognitive Assessment P415, P783

• Neurodegeneration 30, 37.2, 37.3, 53, P1, P316, P740

• Neurodegenerative Diseases 22.2

• Neurodevelopment 5, 45.2, 55, P129, P148, P160, P506, P539, P149, P489, P523

• Neurodevelopmental Disorders 21.2, 21.4, P127, P168, P441, P537

• Neurodevelopmental Disorders, Cannabidiol, CBDV, Translational Models, Clinical Trials P117, P620

• Neuroeconomics P249

• Neuroendocrine P191

• Neuroendocrine Responses P628

• Neuroendocrinology P308

• Neuroepigenetic Editing P459

• Neurofibrillary Tangle P394

• Neurogenesis 57.2, P488

• Neuroimaging 31.4, 32, 32.4, P13

• Neuroimmune Activation P695

• Neuroimmune Mechanisms 46.5, P696

• Neuroimmunology P8, P68

• Neuroinflammation 5.5, P179, P312, P315, P316, P694, P696, P796, P224, P309, P404, P744

• Neurological Disorders P367

• Neuromelanin-Sensitive MRI 50.4, P157, P390

• Neurometabolism P158

• Neuromodulation 4.3, 18, 53, 53.3, 53.4, P325, P331, P698

• Neuronal Ensembles P604

• Neuronal Oscillations P108, P413, P584

• Neuron-Glial Interactions 11, 58.5

• Neurons P220, P224

• Neuropathic Pain 16.2

• Neuropathology P400

• Neuropeptide S P630

• Neuropeptide Y P212

• Neuropeptides 56.3, P4, P88, P98

• Neuropharmacology 50.2, P272

• Neurophysiology 59, 59.5, P533, P614, P806

• Neuroplasticity 3, 3.4, 18.2, P263, P333

• Neuroprotection P272, P569

• Neuropsychiatric Disorders 4, 4.4, 24.2, 30, 40.3, 57.3, 58.5

• Neuropsychiatric Disorders [Schizophrenia, Parkinson’s Disease, Major Depressive Disorder] P393, P531

• Neuropsychiatric symptoms (NPS) P403

• Neuropsychology P783

• Neurostimulation 55, P799

• Neuroticism P38

• Neurotransmission P355

• Neurovascular P579

• NHP 53.5, 58

• Nicotine 46, 46.3

• Nicotine Addiction P608, P640, P693, P702, P732, P765

• Nicotine Dependence P557

• Nicotine Exposure P735

• Nicotine Metabolism P735

• Nicotine Vapor P735, P737

• Nicotine/Substance Use Disorder P738

• Nicotinic Acetylcholine Receptors P738

• Nitrous Oxide P368

• NMDA 3.2, P368

• NMDA Antagonists P215

• NMDA Glutamate Receptors P110, P482

• NMDA Modulators 3

• NMDA Receptor P79, P353, P806

• NMDA Receptor Antagonist P235

• NMDAR P350

• Nociceptin 16.2

• Nociception P446

• Nociceptor 16.3

• Non Human Primate P739

• Noncoding RNA P207

• Nonhuman Primate P729, P777

• Nonhuman Primate Models 7.4

• Non-Invasive Brain Stimulation P498

• Non-Invasive Neuromodulation 18.3, P45, P321, P698

• Nonlinear Analysis P515

• Non-Suicidal Self-injury (NSSI) P156, P165

• Noonan Syndrome P149

• Noradrenergic Signaling 60.4

• Noradrenergic System P103

• Norepinephrine 56, 56.2, 56.3, 56.4, P90, P378, P460, P461, P750

• Normative Modelling P521, P516

• Nos1 P193

• Novel Endpoints 2

• Novel Object Recognition P772

• Novel Therapeutics P31

• Novelty Seeking P772

• Nucleus Accumbens 18.5, 33.4, 58.4, P23, P78, P119, P133, P195, P250, P443, P601, P604, P632, P634, P675, P734, P753, P755, P760, P703

• Nucleus Accumbens (NAA) P675

• Nucleus Accumbens Glutamatergic Afferents P377, P762

• Nucleus Tractus Solitarii P103

• Nutrition P624

• Obesity 4.2, 43.2, P69, P136, P187, P456

• Observational Learning P97

• Obsessive-Compulsive And Related Disorders P420

• Obsessive-Compulsive Disorder (OCD) 20.2, P417, P418, P424, P426, P415, P419, P421, P427, P331, P416, P422, P786

• Obsessive-Compulsive Symptoms P419

• Obstructive Sleep Apnea P588

• Occipital Cortex P550

• Odor Deficits P578

• Olanzapine 43.4

• Older Adults P10, P14, P589

• Oligodendrocytes 7.2, 21.2, 21.3

• Onset P255

• Open Chromatin Regions P531

• Open Label Trials P227

• Open-Label Follow-Up P322

• Operant Behavior P770

• Opioid P691, P766, P731, P408, P607

• Opioid Abuse 35.4, P609, P659, P728, P729, P764

• Opioid Addiction 25.5, 53.3, P616, P661, P677, P750

• Opioid Agonist Treatment P665, P718

• Opioid Antagonist Treatment P624, P729

• Opioid Dependence P741, P746, P750

• Opioid Overdose P728, P745

• Opioid Peptides 16.5

• Opioid System 58.3, P80

• Opioid Tolerance P597, P769

• Opioid Use Disorder 35.3, P198, P401, P624, P660, P696

• Opioid Withdrawal P758, P609, P614, P621

• Optical Biosensors P62, P90, P771, P773

• Optogenetics 20.2, 33.3, 54.4, P458

• Oral Self-Administration P758

• Orbitofrontal Cortex (OFC) P658, P675, P630, P688

• Orexin P594, P597, P748

• Orexin Receptor Antagonist P449

• Orexin/Hypocretin P458

• Orphan Receptors P568

• Oscillations P561

• Ovarian Hormones P246

• Oxidative DNA Damage P11

• Oxycodone P612, P616, P736

• Oxytocin 59.2, P453

• Oxytocin Receptor 33.4

• P300 P546, P584

• PACAP P194

• Pain 16, 16.2, 16.3, 16.4, 16.5, 40.2, P649

• Pain Analgesia P764

• Pain Models P407

• Pain Therapeutics P173, P448

• Pain Therapeutics Profiling P407

• Panic P31

• Panic Attacks P51

• Parabrachial P614

• Parabrachial Nucleus P754

• Paralaminar Nucleus P114

• Paraventricular Nucleus Of The Hypothalamus 11.4

• Paraventricular Nucleus Of The Thalamus 33.2, P100, P109, P196, P203, P279, P414, P443

• Parent - Child Dyads P130

• Parietal Cortex P808

• Parkinson’s Disease 37, 37.2, P382

• parkinson’s Disease Psychosis P569

• Partial Agonist 35.4

• Parvalbumin Fast-Spiking Gabaergic Interneurons 40.3

• Parvalbumin Interneurons P160, P478, P770

• Parvalbumin Interneurons/Perineuronal Nets P582

• Parvalbumin Neurons P502, P776

• Patient Reported Outcomes P337

• Pavlovian Conditioning P203, P760, P771

• PDE10A P575

• Pediatric P329, P424, P559

• Pediatric Clinical Trials P163

• Pediatric Irritability P164, P336

• Perceived Stress 28.4

• Perceptual Decision-Making P468

• Perceptual Distortion Of Appearance P423

• Perceptual Inference 49

• Perforant Pathway (PP) 7.3

• Periaqueductal Grey (PAG) P102

• Perinatal Anxiety 17, 17.1, 17.3

• Perinatal Development P522

• Perinatal Stress 5.3

• Peripheral Blood Marker 27, P296, P347

• Peripheral Nervous System 33.3

• Persistent Avoidance P427

• Personal Space P808

• Personalized Medicine P183, P286

• PET Imaging P63, P198, P434, P484, P684, P696, P739, P106, P16, P186

• PET Imaging Study P471

• PET Tracer P198

• PF-04958242 P495

• PFC P106, P167, P251, P617

• Pharmacodynamics P713

• Pharmacoepidemiology P343, P665

• Pharmacogenetics P172, P292, P344

• Pharmacogenomics P292

• Pharmacokinetics 53.5, P344, P362, P446, P644

• Pharmacology 42.4, P806, P361

• Pharmacotherapy 35, P410, P741, P746, P750

• Phase 1 P75

• Phase 2 P115

• Phase II Clinical Trial P28, P29

• Phosphoproteomics 44.3

• Phosphorylation P501

• Photobiomodulation P325

• Photopharmacology P27

• Pimavanserin P569

• Placebo P802

• Placebo Response P239

• Placenta P514

• Plasma Lactate And Pyruvate P210

• Plasticity P356

• Platelet Serotnin 27.2

• Polygenic Risk Scores 44.2, 45.4, P538, 44, P505, P529, P533, P534

• Polygenic Scores 45.5, P294

• Polysubstance Abuse P200, P613

• Polyunsaturated Fatty Acids P184

• Population Genetics 24, P177

• Population Neuroscience 23

• Population Pharmacokinetics P445

• Population-Based P452

• Positive Affect 54, 54.3

• Positive Allosteric Modulators P242, P722

• Positive Valence 54.2, P797

• Positron Emission Tomography (PET) P201, P327, P338, P438, P512, P644, P796, P651, P708, P686, P542

• Post Traumatic Stress Disorder P23, P41, P52, P70, P78, P82, P172

• Postmortem Brain Tissue 44, P112, P411, P535

• Postmortem Brain Tissue Gene Expression P482

• Postmortem Human Brain P224, P226

• Postmortem Human Brain Study P401

• Postmortem Human Brain Tissue P290, P460, P477, P481, P677

• Postoperative Cognitive Dysfunction P408

• Postpartum 27.1

• Postpartum Anxiety 17.2

• Postpartum Depression P307, P310

• Postpartum Period 5.2

• Posttraumatic Headache 60.4

• Posttraumatic Stress Disorder 31.2, P40, P72, P85, P73

• Post-Traumatic Stress Symptoms P38

• Potential Mechanism P801

• Prazosin 60, 60.2, 60.3, 60.4, 60.5

• Precision Health 48

• Precision Medicine For Depression P291, P341

• Precision Medicine For Mood And Anxiety Disorders P60

• Precision Psychiatry P229, P346, P418

• Preclinical Alzheimer’s Disease P596

• Preclinical Pharmacology 21.2, P410, P447

• Predatory Imminence P374

• Prediction 25.2, P330

• Predictive Models P387, P654

• Predictor Of Treatment Response P521

• Prefrntal Cortex P759

• Prefrontal Circuit Maturation 18.2

• Prefrontal Cortex 1.3, P134, P3, P102, P197, P478, P550, P631

• Pregabalin P728

• Pregnancy 5, 17.2, 27, 27.1, 27.3, P147, P371, P451, P455, P659, P746, P798

• Prelimbic P22

• Prelimbic Cortex 46.4, P385, P457, P749, P760

• Premenstrual Dysphoric Disorder P306

• Prenatal Alcohol Exposure 40.5

• Prenatal Antidepressant Exposure P55

• Prenatal Drug Exposure 1.4, P731

• Prenatal Exposure 22.1, 45.3

• Prenatal Programming P138

• Prenatal Stress Model 5.5

• Prepulse Inhibition P566

• Prescriptions P400

• Preterm Birth 5.3

• Prevention of Alzheimer’s disease P8

• Primates 58.2

• Probabilistic Reversal Learning P789

• Probabilistic Reward Learning P377

• Problem-Level Use P654

• Processing Speed P513

• Prodrome P122, P266, P267, P140

• Progesterone P231, P693

• Pro-Inflammatory Cytokines 14.2, 17.2, 46.4

• Prolactin P527

• Protective Factor P467

• Protein Aggregation P486

• Protein Kinase P487

• Protein Trafficking P394

• Proteomics P6, P112, P401, P618, P681

• Proton Magnetic Resonance Spectroscopy 9.2, P546

• Prucalopride P79

• Psilocin P362, P723

• Psilocybin 34, 34.3, 34.4, P234, P244, P314, P346, P352, P425, P470, P723, P252, P426

• Psilocybin Analog P361, P362

• Psilocybin Therapy P236, P240, P241

• Psychedelic Medicine 34, 34.5, P234, P254, P349

• Psychedelic Therapy P802

• Psychedelics 10.1, 18.4, 19, 34.2, 34.3, 34.4, P218, P236, P244, P252, P349, P352, P360, P361, P362, P425, P572, P723, P801, P426

• Psychiatric Comorbidity P663

• Psychiatric Disorders 32, P287, P452, P514

• Psychiatric Disorders Of Aging 22.2

• Psychiatric Disorders, Cognitive Function P217

• Psychiatric Genetics 57

• Psychiatric Hospitalization P328

• Psychological Wellbeing P470

• Psychometric Properties P783

• Psychomotor Symptoms P513

• Psychopathology P794

• Psychopharmacology P440

• Psychopharmacotherapy P116

• Psychophysiology P85, P784, P803

• Psychosis 18.2, 39, P113, P175, P494, P511, P532, P541, P550, P553, P555, P559, P586

• Psychosis And Memory P542

• Psychosis-Risk P500, P517, P544

• Psychostimulant 4.3

• Psychostimulants P122

• Psychotherapy 19, 34.3, 54.1, P60, P244

• Psychotic Disorder P507, P544, P547, P583, P526

• Psychotomimetic Effects P350

• Psychotropic Medications P501

• PTSD 36, 36.3, 36.4, P29, P33, P37, P41, P43, P49, P57, P58, P59, P64, P65, P67, P83, P84, P86, P96, P105, P173, P176, P213, P680, P784, P785

• PTSD Depression 31.4

• PTSD, Prediction, Causal Modeling, Trajectory Modeling, Cortisol P67

• Puberty 15.1, 26.2, P137

• Public Health P454

• Punishment P726

• Pyramidal Neuron P536

• Quantitative Electroencephalography (qEEG) P369, 3.5

• Quantitative Relaxometry (QR) 7.4

• Race Disparities 5, 28.3, P784

• Racial Differences 14.2, 14.5

• Racial Ethnic Minority 5.3

• Racial Segregation 14

• Racial/Ethnic Differences P440, P664

• Racism 14.4, 55

• Randomized Balaam Crossover Design P322

• Randomized-Controlled Trial 60.5, P172, P240, P241, P241

• Rapid-Acting Antidepressant P215, P235

• Rare Genetic Variation P151, P421

• Rare Variation P422

• Rats P733, P18

• Rbfox1 P478

• RCT P44, P415

• Real-Time fMRI Neurofeedback 54.3, P45

• Recent Onset Psychosis P490

• Recollection And Familiarity P412

• Recordings P774

• Recruitment P450

• Reelin P216

• Reformulation P29

• Reinforcement Learning P90, P658, P757, P791, P807

• Reinforcement Learning Modelling P519

• Reinstatement P736

• Relapse P319

• Relapse And Hospitalization P490

• Relapse Biomarkers P647

• Relapse Prevention 60.3

• Reliability 39, 39.3

• Rem Sleep P595

• Remission P330, P538

• Remitted Depression P259

• Repetitive Transcranial Magnetic Stimulation (rTMS) P153, P239, P321, P323, P386, P423, P557, P806, P73, P281

• Reproductive Affective Disorder P231, P306

• Reproductive Psychiatry P455

• Research Domain Criteria (RDoC) P262, 40, P781

• Resilience P211, P301

• Respiratory Depression P745

• Resting State P685

• Resting State Brain Imaging P266

• Resting State Functional Connectivity 48.5, P40, P52, P146, P279, P281, P300, P346, P387, P389, P402, P499, P584, P633, P660, P735

• Resting State Networks P557, P698

• Resting-State fMRI 43.2, P138, P256, P304, P336, P419, P682

• Retrieval Induced Forgetting P779

• Reversal Learning P658

• Reward 26.2, 33.3, 37.3, 56, P249, P351, P376, P384, P701, P732, P755, P786, P791, P204, P636, P770

• Reward And Aversion P749

• Reward Anticipation P189, P640, P699

• Reward Circuitry 43, P109, P276, P757

• Reward Deficit P370

• Reward Devaluation P632

• Reward Expectancy P188, P326

• Reward Learning P604

• Reward Neural Circuitry 26

• Reward Neural Network P619

• Reward Prediction Error P656

• Reward Processing P285

• Reward Representation P99

• Reward Sensitivity 54.1, P270, P652

• Reward-Based Decision-Making 43.2

• Ribotag P171

• Right Temporo-Parietal Junction 8.3

• Risk P656

• Risk And Resilience P48, P107

• Risky Behaviors P179

• Risky Decision-Making P202

• RNA-Seq 7.3, 15.3, 58, 58.3, P532, P617, P59, P134, P288, P483, P170, P171, P113, P205

• Rodent Models 22.1, 53.3

• Rodents P688

• Rtms P9, P42

• Rumination P257

• S1P Receptor P410

• Safety Learning P72, P94, P101

• Salience P98

• Salience Network P277, P645

• Salvinorin A P80

• Sample Size And Power 23

• Sappα P7

• Sappβ P7

• Schizophrenia (SCZ) 2, 8.4, 9, 9.3, 21.1, 24.4,39.2, 44, 44.2, 44.3, 44.4, 44.5, 50, 57.4, P6, P114, P176, P475, P476, P478, P479, P480, P482, P488, P489, P501, P503, P509, P512, P514, P519, P523, P527, P529, P532, P533, P535, P538, P539, P540, P543, P545, P549, P550, P552, P554, P556, P557, P561, P565, P572, P577, P584, P786, P795, P535, P481, P495, P522, P526, P562, P785, P486, P487, P508, P564, P578

• Schizophrenia And Bipolar Disorders 39.4

• Schizophrenia And Cognition P595

• Schizophrenia Negative Symptoms P496, P570

• Schizophrenia Novel Treatment P479, P492, P570

• Schizophrenia- Novel Treatment P180, P568

• Schizophrenia Spectrum Disorders P518, P579

• Schizophrenia Subtype P485

• Schizophrenia Subtypes P481

• Schizophrenia Therapeutics P585

• Schizophrenia, Synaptic Aberrations P484

• Schizophrenia; Technology P496

• Schizotypal Personality Disorder 39.5

• SCN2A P111

• Scopolamine P208

• Seizure P410

• Selective Serotonin Reuptake Inhibitors (SSRIs) 27.2, P270

• Self-Administration 1, 1.5, 35.1, P674, P766, P674, P766, P615, P736, P737, P764

• Self-Harm P165

• Self-Referential Processing 31.3

• Senescence P340

• Sensitive Period 42.2

• Sensitization 16.4, P430

• Sensorimotor 4.4, P120

• Sensory Gating P544

• Sensory Neurobiology 49

• Septum P432

• Serotonin 18.5, P62, P106, P167, P179, P204, P311, P357, P371, P379, P434, P789

• Serotonin 1A Receptors 28.4

• Serotonin 5-Ht2A Receptor 35.4, P352, P360

• Serotonin And Norepinephrine Reuptake Inhibitor P347

• Serotonin Reuptake Inhibitors 27

• Serotonin Transporter P347

• Sertraline 27.1

• Serum Levels P445

• Severe Major Depressive Disorder 54.3

• Sex 15

• Sex And Gender P57

• Sex Differences 1.2, 11.2, 15.4, 22, 22.1, 22.3, 22.4, 37, 37.2, 42.3, 56.4, P663, P3, P11, P19, P21, P47, P102, P170, P212, P313, P387, P461, P543, P622, P650, P651, P693, P704, P714, P726, P738, P761, P762, P790, P247, P664, P132, P214, P430, P736, P308, P92, P202

• Sex Hormones 33.2, P219

• Sex Steroid Hormone Receptors P196

• Sex-Specific P605

• Sex-Specific Effects P136, P279, P456, P678

• Sexual Orientation P587

• Sharp-Wave Ripples 59.2

• Short-Term Synaptic Depression P611

• Sickle Cell Disease P449

• Sign-Tracking P632

• Simulated Driving P705, P706

• Simvastatin P245

• Single Cell Omics 11, P58

• Single-Cell RNA Sequencing 33.4, 57.3, 58.3, 58.5, P609, P616, P681, P668

• Single-Nucleus RNA Sequencing 58.2, 58.4, P24, P211, P432, P460, P615, P677

• Single-Unit Electrophysiology In Vivo 53.5, 56.4, P473, P632

• Sirtuins P295

• Skin Conductance Response P72

• SLC6A1/GAT1 P221

• Sleep P86, P206, P263, P592

• Sleep Deprivation 45.3, P595

• Sleep Disorders P593

• Sleep Disturbances 30, P10, P125, P590, P620, P697, P591

• Sleep Oscillations P589, P596

• Sleep Spindles P544

• Sleep-Dependent Learning P596

• Slice Electrophysiology 20.5, P355, P385, P597, P756, P776

• Slow Wave Sleep P257

• Slow-Wave Activity P263

• Smoking P652, P666

• Smoking Cessation P640

• Smoking Onset Age P679

• SNP P295

• SNP Variation 33.4

• Social 8.2

• Social And Behavioral Deficits P74, P133, P459, P473

• Social Anxiety P74

• Social Anxiety Disorder P63, P788, P28

• Social Behaviors P457, 10.2, 11, 11.5, 18.5, 26.2, 33, 33.2, 42, 42.1, 42.3, 42.4, 45.5, P222, P414, P650

• Social Buffering 26

• Social Cognition 8.3, 8.4, P41, P638

• Social Defeat Stress 33.1, P206, P211, P248, P313, P315, P357

• Social Deficits 33, P458, P474

• Social Determinants Of Health 5.4

• Social Determinants Of Health Inequity P709

• Social Factors And Functioning P165

• Social Functioning 54.2, P525, P576

• Social Hierarchy 14.4

• Social Impact Model 41

• Social Interactions 11.4, 33, P453

• Social Isolation P458, P759

• Social Media Use P450

• Social Perception 8

• Social Play Behavior P170

• Social Processing 42.2, P650

• Social Recognition Memory P412

• Social Rejection 26.1, P792

• Social Reward P787

• Social Stress Buffering P25

• Social Touch 33.3

• Somatostatin P385, P208

• Sonic Hedgehog Signaling 4.2

• Spatial Memory 37.4, P96, P135

• Spatial Transcriptomics 58.4, P2, P460, P668

• Spine Morphogenesis P358

• Splice Site Mutations 57.1

• Splice Variants P20

• Splicing 57

• SSRI P285

• Startle P42

• Statins P245

• Statistical Methods 24.3, P162, P642

• Stem Cells P293

• Stigma 26.1, 41

• Stimulant Use Disorder P707

• Stimulants P451, P453, P725

• Stratification P516

• Stress P143, P256, P370, P582, P684, P20, P209, P247, P251, P310, P376, P680

• Stress And Adversity P147

• Stress And Anxiety Behavior P68, P378

• Stress And Depression 6, 26.3

• Stress And Trauma 36.5

• Stress Coping P253, P358

• Stress Hormones P688

• Stress In Adolescence P110

• Stress Models P171

• Stress Resilience P253

• Stress Resilience And Susceptibility P55, P248

• Stress Response Circuitry 60.2

• Striatal Dopamine Signaling P771, P809

• Striatum 20.2, 43.3, P583, P699, P763

• Structural Adversity 45.4

• Structural And Functional Connectivity P647

• Structural Connectivity P801

• Structural Covariance Analyses P545

• Structural MRI 9.3, P513

• Structural Racism 5.2

• Structural Stigma P587

• Structural Stressors 45

• Subchronic Ketamine Model P474

• Subcortical Volume P521, P637

• Subgenual Anterior Cingulate Cortex P233

• Subgroups P488

• Subjective Effects P240, P241, P439, P716

• Substance Abuse 53.4, P683

• Substance Abuse Disorders 34.4, P705, P629

• Substance Use 14, P704

• Substance Use Disorders P676, 34, 56.5, P644, P669, P699

• Substantia Nigra P157

• Sudden Cardiac Death P526

• Suicidal Behavior 28.4, 51.2, P142, P590

• Suicidal Ideation 28.2, P142, P246, P268, P590, P780, P300

• Suicidality P799, P332

• Suicide 28, P142, P231, P269, P280, P466, P467

• Suicide Attempt 28.3, 48.4, P165, P296, P300, P365, P465, P471

• Suicide Behavior Severity P165

• Suicide Mechanisms P465

• Suicide Risk Factors 28.5, P213, P261, P275, P464, P465, P466

• Superior Orbitofrontal Cortex P188

• Supplementary Motor Cortex 20.2

• SV2A PET imaging P484

• Symptom Dimensions P281

• Synapse P3, P310

• Synapse Loss P312

• Synapses P114, P209, P382

• Synaptic Connections P776

• Synaptic Density P198

• Synaptic Function P617

• Synaptic Orgnization P548

• Synaptic Plasticity 18, 19, 20.5, P250, P353, P355, P610

• Synaptogenesis P327

• Synaptosomes P401

• Synthetic Cannabinoids 1.2

• Synthetic Psychoactive Cathinones P744

• Systemic Inflammation P272

• Systems Neuroscience P108

• Systems Pharmacology P670

• TAAR 1 P574

• TAAR1 P180, P492

• TAAR1 Knockout Mice P574

• Tail Suspension Test P425

• Tardive Dyskinesia P491, P558

• Target Engagement 54.1, P564

• Targeted Cognitive Training P785

• Task fMRI 51, 51.1, P44, P187, P512, P648

• Task-Based Functional Connectivity 25.2, P299

• Taste P468

• Tau P394

• TBI P26, P37

• TCB-2 P360

• Technology P592

• Telemetry P206

• Telomere Length P15

• Telomeres P17

• Temporal Pole P70

• Test-Retest Reliability P515

• Thalamo-Cortical Connectivity P524, P544

• Thalamus P637, P757, P769

• THC 1.5, P18, P618, P714, P743

• the COVID-19 pandemic 14.3, 14.4, P276, P713

• The Dimensional Anhedonia Rating Scale P337

• Therapeutic Alliance P240

• Therapeutic Approach 42

• Therapeutic Drug Monitoring P563, P445

• Therapeutic Interventions 22.2

• Therapy 16

• Theta Band Oscillatory Measures 59.2

• Theta Burst Transcranial Magnetic Stimulation 3.3, P71, P320, P498

• Theta-Burst Stimulation P324, P326

• Threat Conditioning P169

• Threat Faces 36.4

• Threat Reactivity P70

• Thyroid Hormone P265

• Tianeptine P285

• Time Estimation P712

• Time Varying Functional Connectivity P768

• Time-Frequency P778

• Timing P600

• TMS P65, P233, P331

• TMS targeting P282

• TMS-EEG P324, P366, P380

• TNF-alpha P554

• Tobacco 34.4, P676, P719

• Tobacco Dependence P686

• Toll-Like receptors (TLRs) P160

• Tools For Building Your Successful Career 38

• Touch 16.3

• Touchscreen 40.4, 40.5, P751

• Touchscreen Cognitive Testing P502

• Tourette Syndrome P116

• Trace Amines P574

• Trajectories P400

• Transcranial Current Stimulation P494

• Transcranial Direct Current Stimulation (tDCS) P655

• Transcranial Magnetic Stimulation P389

• Transcript Isoforms 57.3, P536

• Transcriptome 44.5, P290, P603, P689

• Transcriptome Biology P612

• Transcriptomics 37.3, 58, 58.2, P8, P293, P307, P356, P420, P602, P659, P667

• Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) 22.4

• Transdiagnostic 7, 32.4, P782, P794

• Transgender 26, 26.2

• Transgenerational P756

• Transition To Broad Psychosis Spectrum Psychopathology 12, 18.2, P546

• Translational Animal Models 1.4, P314, P671

• Translational Approaches To Drug Development 13

• Translational Biomarker Development 40.5

• Translational Cognitive Testing 40.3

• Translational Neuroscience P469

• Translational Research 13, 18, 29, 40, 59, 59.4, 59.5

• Translational Studies 16

• Translocator Protein (TSPO) P651

• Transplantation P190

• Trauma P43, P684

• Trauma Exposure P493, P661

• Traumatic Brain Injury 60.4, P413

• Treatment P173

• Treatment Mechanisms 7, 7.4

• Treatment Outcome P624

• Treatment Outcome Prediction P286, P520

• Treatment Prediction P334

• Treatment Resistant Depression P230, P300, P322, P366, P210, P216, P227, P234, P244, P245, P318, P321, P323, P324, P341, P372

• Treatment-Resistance P317, P538, P562, P388

• Treatment-Resistant Schizophrenia P563

• Treatment-Response P545

• TSPO P186

• Tumor Necrosis Factor P25

• TWAS 24.5, P514

• Two-Photon Calcium Imaging P468, P580

• Ubiquitination P486

• Ulotaront P492

• Ultra-High Field Mri P298

• Ultrasonic Vocalization P102

• Ultrasonic Vocalization (USV) Model P359

• Unbiased Effect Size Estimation 23

• Uncertainty P90, P428, P519, P53

• Unconditioned Responses P82

• Vaccine 35.3

• Vaccine Hesitancy P454

• Valbenazine P491

• Valence P95, P381

• Value-Based Decision-Making P428, P653

• Vapor 1.4, P743

• Vasopressin 1A Receptor Antagonist P469

• Vasopressin 1B Antagonist P229

• Venlafaxine P344

• Ventral Hippocampus 45.4, P35, P55, P100, P377, P582, P776

• Ventral Pallidum P381, P599

• Ventral Striatum P98, P427

• Ventral Tegmental Area (VTA) 50.2, 58.3, P288, P607, P775, P211, P748

• Ventral Visual Stream P258

• Ventrolateral Prefrontal Cortex P427

• Ventromedial Prefrontal Cortex 25.4, 31.3, 36.2

• Verbal Episodic Memory 9.4

• Verbal Memory P639

• Vesicular Glutamate Transporter (VGLUT) 37.2

• veterans P173, P529, P780, P73, P261

• Viloxazine P106, P167, P434

• Violence P528

• Viral Vectors 53, 58.2

• Virtual Reality P71, P72

• Virus Infection P397

• Visual Cortex 7.2

• Visual Perception P423

• Visuospatial Working Memory P536, P502

• vlPFC P326

• VMAT2 P438

• VTA P430

• Wake-Promoting P594

• Wheel Running P190

• White Matter Development 21.1, 31.1, P144

• White Matter Microstructure 7, 7.5, P47, P124

• Whole-Body Plethysmography P745

• Whole-Brain Rodent Imaging P249, P769

• Williams Syndrome P402

• Withdrawal 1.2, P598, P719, P741, P746, P750

• Women P86, P643

• Women’S Health P16, P308

• Women’S Mental Health P84, P591, P665

• Word Embedding Clustering 52

• Working Memory 39, 39.3, P18, P64, P131, P509, P510, P512, P786

• Working Memory Capacity 39.5

• Working Memory Fmri P277, P442

• X Chromosome P219

• Xanomeline P480

• Young Adults P276

• Youth P289, P329

• Zebrafish P128, P148

• Zif268 P766

• Zinc P730

• Zuranolone P242

• Α5 GABAA Positive Allosteric Modulator P437

• ΔFosB P309